UNIGENE LABORATORIES INC·4

Oct 1, 4:24 PM ET

Mehta Nozer 4

4 · UNIGENE LABORATORIES INC · Filed Oct 1, 2012

Insider Transaction Report

Form 4
Period: 2012-09-27
Mehta Nozer
Vice Pres. Biological R&D
Transactions
  • Award

    Stock Option

    2012-09-27+190,601768,181 total
    Exercise: $0.25Exp: 2022-09-26Common Stock (190,601 underlying)
  • Award

    Stock Option

    2012-09-27+630,8751,399,056 total
    Exercise: $0.10From: 2013-09-27Exp: 2022-09-26Common Stock (630,875 underlying)
Footnotes (1)
  • [F1]95,300 stock options will become exercisable on August 1, 2013 and 95,301 stock options will become exercisable on August 1, 2014

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    PRIMARY DOCUMENT